NCT03554707 2022-02-08
SGT-53 in Children With Recurrent or Progressive CNS Malignancies
SynerGene Therapeutics, Inc.
Phase EARLY_PHASE1 Unknown
SynerGene Therapeutics, Inc.
Jiangsu HengRui Medicine Co., Ltd.
Oncolys BioPharma Inc
Shenzhen SiBiono GeneTech Co.,Ltd